Showing results (291-300 of 301) with videos related to
Sort By:
Pageof 31
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 22, 2023
FDA Approval Summary: Mirvetuximab Soravtansine-Gynx for FRα-Positive, Platinum-Resistant Ovarian CancerAsma Dilawari, Mirat Shah, Gwynn Ison, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 14, 2025
FDA Approval Summary: Tovorafenib for Relapsed or Refractory BRAF-Altered Pediatric Low-Grade GliomaSonia Singh, Diana Bradford, Somak Chatterjee, et al.Clinical Pharmacology and Therapeutics|June 5, 2025
Using Quantitative Approaches to Optimize Dosages for New Combinations and Subsequent Indications for Oncology DrugsWei Gao, Jiang Liu, Cynthia J Musante, et al.The American Journal of Tropical Medicine and Hygiene|April 2, 2014
Immune responses to O-specific polysaccharide and lipopolysaccharide of Vibrio cholerae O1 Ogawa in adult Bangladeshi recipients of an oral killed cholera vaccine and comparison to responses in patients with choleraTaher Uddin, Amena Aktar, Peng Xu, et al.Scientific Reports|October 3, 2023
M gene targeted qRT-PCR approach for SARS-CoV-2 virus detectionMd Murshed Hasan Sarkar, Showti Raheel Naser, Sanjana Fatema Chowdhury, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2020
FDA Approval Summary: Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf Injection for Subcutaneous Use in Patients with HER2-positive Breast CancerJennifer J Gao, Christy L Osgood, Yutao Gong, et al.Mbio|December 22, 2016
Single-Cell Analysis of the Plasmablast Response to Vibrio cholerae Demonstrates Expansion of Cross-Reactive Memory B CellsRobert C Kauffman, Taufiqur R Bhuiyan, Rie Nakajima, et al.AACE Endocrinology and Diabetes|April 6, 2026
Early-Onset Type 2 Diabetes in Bangladesh: National Estimates and Risk CorrelatesMashfiqul Hasan, Md Shahed Morshed, Tania Tofail, et al.Journal of Clinical Pharmacology|April 2, 2008
New era in drug interaction evaluation: US Food and Drug Administration update on CYP enzymes, transporters, and the guidance processShiew-Mei Huang, John M Strong, Lei Zhang, et al.Mbio|November 18, 2020
Humans Surviving Cholera Develop Antibodies against Vibrio cholerae O-Specific Polysaccharide That Inhibit Pathogen MotilityRichelle C Charles, Meagan Kelly, Jenny M Tam, et al.Pageof 31